Centerpoint Advisors’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
Other funds holding CL
Centerpoint Advisors's CL Position: Q2 2026 in Review
Centerpoint Advisors reduced its Colgate-Palmolive (CL) stake by 27% in Q2 2026, selling an estimated $15.5K and leaving 470 shares worth $43K. The position accounts for 0.01% of the portfolio, ranked #173.
Centerpoint Advisors first reported a position in CL in Q1 2018 and has held it in 27 quarters since. The position peaked at $112K in Q1 2018. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Centerpoint Advisors held 470 shares of Colgate-Palmolive worth $43K as of Q2 2026.
- Centerpoint Advisors sold 177 Colgate-Palmolive shares in Q2 2026, an estimated $15.5K.
- Colgate-Palmolive made up 0.01% of Centerpoint Advisors's portfolio in Q2 2026, its #173 holding.
- Centerpoint Advisors first reported a position in Colgate-Palmolive in Q1 2018 and has held it in 27 quarters since.
- Centerpoint Advisors's Colgate-Palmolive position peaked at $112K in Q1 2018.
- 2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Centerpoint Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.